Dermapharm Holding SE
XETRA:DMP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Dermapharm Holding SE
XETRA:DMP
|
DE |
|
Nexa Resources SA
NYSE:NEXA
|
LU |
|
A
|
Aegean Airlines SA
XBER:32A
|
GR |
|
P
|
Paladin Energy Ltd
F:PUR
|
AU |
|
N
|
Nutrien Ltd
NYSE:NTR
|
CA |
|
Nikola Corp
NASDAQ:NKLA
|
US |
|
Aptiv PLC
NYSE:APTV
|
IE |
|
B
|
BriQ Properties REIC
ATHEX:BRIQ
|
GR |
|
V
|
Verbund AG
SWB:OEWA
|
AT |
|
Coles Group Ltd
ASX:COL
|
AU |
|
Aptose Biosciences Inc
F:LTI0
|
CA |
|
P
|
PIE Industrial Bhd
KLSE:PIE
|
MY |
|
N
|
Nanosonics Ltd
F:OQS
|
AU |
|
M
|
Morgan Stanley
SWB:DWD
|
US |
|
G
|
Genmab A/S
LSE:0MGB
|
DK |
|
Mazda Motor Corp
F:MZA0
|
JP |
|
H
|
Hexagon Purus ASA
XBER:0QJ
|
NO |
|
M
|
Muenchener Rueckversicherungs Gesellschaft in Muenchen AG
F:MUV2
|
DE |
|
Herbal Dispatch Inc
F:HA9
|
CA |
|
Celsius Holdings Inc
NASDAQ:CELH
|
US |
|
A
|
Akamai Technologies Inc
DUS:AK3
|
US |
|
I
|
IPH Ltd
OTC:IPHLF
|
AU |
|
Farmer Bros Co
NASDAQ:FARM
|
US |
|
Bunge Global SA
F:Q23
|
US |
Wall St Price Targets
DMP Price Targets Summary
Dermapharm Holding SE
According to Wall Street analysts, the average 1-year price target for DMP is 51 EUR with a low forecast of 44.44 EUR and a high forecast of 63 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DMP's stock price target?
Price Target
51
EUR
According to Wall Street analysts, the average 1-year price target for DMP is 51 EUR with a low forecast of 44.44 EUR and a high forecast of 63 EUR.
What is the Revenue forecast for Dermapharm Holding SE?
Projected CAGR
5%
Over the last 10 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 5 years is 5%.
What is the Gross Profit forecast for Dermapharm Holding SE?
Projected CAGR
4%
Over the last 10 years, the compound annual growth rate for Gross Profit has been 16%. The projected CAGR for the next 3 years is 4%.
What is the Operating Income forecast for Dermapharm Holding SE?
Projected CAGR
6%
Over the last 10 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 6%.
What is the Pre-Tax Income forecast for Dermapharm Holding SE?
Projected CAGR
8%
Over the last 10 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 8%.
What is the Net Income forecast for Dermapharm Holding SE?
Projected CAGR
8%
Over the last 10 years, the compound annual growth rate for Net Income has been 26%. The projected CAGR for the next 3 years is 8%.
